Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Legal Officer

Chief Operating Officer

CEO, Managing Director

Chief Financial Officer

Chief Medical Officer

President, R&D

See Remarks

Executive VP, Operations

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	CEO, Managing Director
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-26	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-02-26	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-02-26	Premium	sold	Premium	Premium	Premium	CEO, Managing Director
2023-09-18	Premium	sold	Premium	Premium	Premium	President, R&D
2023-07-10	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-06-23	Premium	gifted	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-16	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-
2023-06-13	Premium	acquired	Premium	Premium	Premium	-

QURE - uniQure NV Stock Price, Fair Value and News

Latest Insider Trading transactions for QURE